⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15404700 | 0.75 | — | — | |
| SCHEMBL726548 | 0.73 | — | — | |
| SCHEMBL1133825 | 0.69 | — | — | |
| SCHEMBL15403068 | 0.69 | — | — | |
| SCHEMBL3114431 | 0.69 | — | — | |
| SCHEMBL9967757 | 0.69 | — | — | |
| SCHEMBL15402409 | 0.69 | — | — | |
| SCHEMBL4592200 | 0.67 | — | — | |
| SCHEMBL15403354 | 0.67 | — | — | |
| SCHEMBL15081202 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572098-A2 | METHOD OF TREATING SNORING AND OTHER OBSTRUCTIVE BREATHING DISORDERS | Sohn, Stearns & Stern (US) | 2005-09-14 | — | — | EP | disclosed |
| US-20040258621-A1 | Method of treating snoring and other obstructive breathing disorders | SOHNSTEARNS & STERN | 2004-12-23 | — | — | US | disclosed |
| WO-2004034973-A2 | METHOD OF TREATING SNORING AND OTHER OBSTRUCTIVE BREATHING DISORDERS | STERN WARREN (US) | 2004-04-29 | — | — | WO | disclosed |
| US-4628098-A | Including Prevacid (TM) lansoprazole, 2-(3-methyl-4-(2,2,2-trifluoroethoxy)-5-methyl-pyrid-2 -yl)methylsulfinylbenzimidazole; proton pump inhibitors, antiulcer, antisecretory agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-12-09 | — | — | US | disclosed |
| EP-0174726-A1 | Pyridine derivatives and their production | Takeda Chemical Industries, Ltd. (JP) | 1986-03-19 | — | — | EP | disclosed |